Trial Profile
Safety and Cost-Effectiveness of a Clinical Protocol Implemented to Standardize the Use of Crotalidae Polyvalent Immune Fab Antivenom at an Academic Medical Center.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2012
Price :
$35
*
At a glance
- Drugs Crotalidae polyvalent immune Fab(ovine) (Primary)
- Indications Snake venom poisoning
- Focus Therapeutic Use
- 19 Apr 2012 New trial record
- 30 Mar 2012 Results published in Pharmacotherapy.